Slide Show Understanding Biomarker Testing In Non Small Cell Lung Cancer Testing is a necessary first step in opening the door to precision medicine and targeted treatments which can lead to improved survivorship and quality of life. after a cancer diagnosis, biomarker testing can help connect patients with the right treatment at the right time. Biomarker testing is a way to look for genes, proteins, and other substances (called biomarkers or tumor markers) that can provide information about cancer. each person’s cancer has a unique pattern of biomarkers. some biomarkers affect how certain cancer treatments work. biomarker testing may help you and your doctor choose a cancer.
Comprehensive Biomarker Testing For Lung Cancer Lung Cancer Research So we know that biomarker testing connects the right patient to the right treatment at the right time and potentially to the right clinical trial, but there also are some challenges and interventions are necessary, and that’s going to really frame our conversation today. Biomarkers can be used for several purposes: assess an individual’s risk of developing cancer. determine an individual’s risk of cancer recurrence. predict the likelihood that a given therapy will work for a specific patient. monitor a disease’s progression to determine if a therapy is working. how biomarkers guide targeted therapies. Where asco stands on biomarker testing . asco unequivocally supports personalized cancer therapy: delivering the right treatment, to the right patient, at the right time. biomarker testing, particularly ngs, represents the leading edge of technological innovation in this space, with potential to drive down overall testing costs and improve. The national cancer institute defines a biomarker as a biological molecule— found in blood, body fluids, or tissues that is a sign of a normal or abnormal process, a condition or disease. cancer biomarkers can include: proteins. gene mutations (changes) gene rearrangements. extra copies of genes.
Comments are closed.